Efficacy in the control of bleeding episodes and in prophylaxis
| . | N (%) . | Median dose (IU/kg) . |
|---|---|---|
| Bleeding events treated with rVIII-SingleChain | 848 | 34.7 |
| Bleeding events with investigator assessment | 835 (100) | 34.7 |
| Efficacy rating | ||
| Excellent | 603 (72.2) | 32.2 |
| Good | 180 (21.6) | 43.2 |
| Moderate | 52 (6.2) | 93.4 |
| Poor/no response | 0 (0) | N/A |
| Number of injections required to treat | ||
| 1 | 686 (80.9) | 31.2* |
| 2 | 107 (12.6) | 35.6* |
| ≥3 | 55 (6.5) | 37.6* |
| . | N (%) . | Median dose (IU/kg) . |
|---|---|---|
| Bleeding events treated with rVIII-SingleChain | 848 | 34.7 |
| Bleeding events with investigator assessment | 835 (100) | 34.7 |
| Efficacy rating | ||
| Excellent | 603 (72.2) | 32.2 |
| Good | 180 (21.6) | 43.2 |
| Moderate | 52 (6.2) | 93.4 |
| Poor/no response | 0 (0) | N/A |
| Number of injections required to treat | ||
| 1 | 686 (80.9) | 31.2* |
| 2 | 107 (12.6) | 35.6* |
| ≥3 | 55 (6.5) | 37.6* |
N/A, not applicable.
IU/kg for first injection.